Enanta Pharmaceuticals Inc Q3 FY2023 Earnings Call

Enanta Pharmaceuticals Inc (ENTA)

Earnings Call FY2023 Q3 Call date: 2023-08-07 Concluded

Quarter scorecard

Revenue

$18.89M

-3% YoY

Diluted EPS

$-1.86

Net income

-$39.06M

Royalty $18.89M

-3%

License $0